Τόμος 27 (2009) – Τεύχος 1 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 27 (2009) – Issue 1– Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Ευγενία Γιαννακοπούλου

Σχολή Επαγγελμάτων Υγείας και Πρόνοιας, Tεχνολογικό Εκπαιδευτικό Ίδρυμα Αθηνών ΑΤΕΙ Αθηνών, Αιγάλεω, Αθήνα, Ελλάς

Evgenia Yiannakopoulou

Faculty of Health and Caring Profesions Technological Educational Institute of Athens, Athens Hellas

2. Carlson HE.: Gynaecomastia. N. Engl. J. Med. 303: 795-799 (1980)

3. Gikas P., Mokbel B.: Management of gynaecomastia:an update. Int. J. Clin. Pract. 61: 1209-1215 (2007)

4. Ηands L.J., Greenhall M.J.: Gynaecomastia. Br. J. Surg. 78: 907-911 (1991)

5. Neuman J.F. Evaluation and treatment of gynaecomastia. Am. Fam. Physician 55: 1835-1844 (1997)

6. Cornes P.G.S., Hole H.C.: Breast 10: 544-545 (2001)

7. Echman A., Dobs A.: Drug induced gynaecomastia. Expert Opin. Drug Saf. 7: 691-702 (2008)

8. Huques F.C., Gourlot C., Le Jeunne C.: Drug induced gynaecomastia. Ann. Med. Interne (Paris) 151: 10-17 (2000)

9. Τhompson D.F., Carter J.R.: Drug induced gynaecomastia. Pharmacotherapy 13: 37-45 (1993)

10. Kiortsis D.N., Filippatos T.D., Mikhailidis D.P., Elisaf M.S., Liberopoulos E.N.: Statin associated adverse effects beyond muscle and liver toxicity. Atherosclerosis 195: 7-16 (2007)

11. Niewoehner C., Schorer A.: Gynaecomastia and breast cancer in men. BMJ 336: 709-713 (2008)

12. Yiannakopoulou E., Damianou Ch., Bamia Ch., Papadopoulos J.S.: Αdequacy of safety data reporting in randomized clinical trials comparing coxibs with non selective NSAIDs. Epitheor. Klin. Farmakol. Farmakokinet. 23: 42-43 (2005)

13. Yiannakopoulou E.: Quantification of adverse drug reations-the role of systematic review-meta-analysis. Iatriki 93: 133-142 (2008)

14. Yiannakopoulou E.: Cephalosporin induced haemolytic anaemia in surgical patients:systematic review. Rev. Pharmacol. Pharmacokinet. Intern. Ed. 22: 363-365 (2008)

15. Stein E., Illingworth R., Kwiterovich P.: Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia. JAMA 281: 137-144 (1999)

16. Black D., Bakker-Arkemma R., Nawrocki J.: An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA Reductase Inhibitor. Arch. Intern. Med. 158: 577-584 (1998)

17. Oteri A., Catania M., Travaglini R., Russo A., Giustini S., Caputi A., Polymeni G.: Gynaecomastia possibly induced by rosuvastatin. Pharmacotherapy 28: 549-551 (2008)

18. Αerts J., Karmochkine M., Raguin G.: Gynaecomastia due to pravastatin. Presse Méd. 28: 787 (1999)

19. Hammons K.B., Edwards R.F., Rice W.Y.: Golf inhibiting gynaecomastia associated with atorvastatin treatment. Pharmacotherapy 26: 1165-1168 (2006)

20. Adverse Drug Advisory Committee. Simvastatin and adverse endocrine effects in men. Aust. Adverse Drug React. Bull. 14: 3 (1985)

21. Αnonymous.: Pharmaceutical preparations are usually the cause of gynaecomastia. Lakartindingen 93: 489-490 (1996)

22. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., Janecek E., Domeck C., Greenblatt D.J.: A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30: 239-245 (1981)

23. Philpot C., Morlay J.: Health issues unique to the aging man. Geriatr. Nurs. 21: 234-240 (2000)

24. Adverse Drug Advisory Committee. Drug induced gynaecomastia. Aust, Adverse Drug React. Bull. 16: 3 (1997)

25. Carvajal A., Macias D., Gutierriez A., Ortega S., Sainz M., Martin Arias L.H., Velasco A.: Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System. Drug Saf. 30: 527-531 (2007)

26. Prisant L.M., Chin E.: Gynaecomastia and hyperten-sion. J. Clin. Hypertens. (Greenwich) 7: 245-254 (2005)

27. Μalaga I., Sanmarti F.: Two cases of painful gynaecomastia and lower extremity pain in association with pregabalin therapy. Ιntern. League Epileps. 47: 1576-1579 (2006)

28. Carvajal A., Martin Arias L.H.: Gynaecomastia and sexual disorders after the administration of omeprazole. Am. J. Gastroenterol. 90: 1028-1029 (1995)

29. Gardette V., Vezzoci D., Maiza G.C., Montastruc J.L., Olivier P.: Gynaecomastia associated with fenofibrate. Ann. Pharmacother. 41: 508-511 (2007)